Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Cutan Med Surg ; 23(4): 370-379, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31010295

RESUMO

BACKGROUND: 5-aminolevulinic acid photodynamic therapy (PDT) for genital warts is effective, safe, and can prevent recurrence. It is believed that PDT can induce immune responses, but the mechanism is not completely understood. OBJECTIVES: The objectives of this article are to confirm the effect of PDT for genital warts on local immunity and to investigate the recruitment and significance of immune cells in tissues. METHODS: Local immune changes in T lymphocytes (CD3+, CD4+, CD8+), plasmacytoid dendritic cells (pDCs) (CD123+), and myeloid dendritic cells (CD1a+) after PDT in patients were evaluated by immunohistochemistry staining. Changes in mRNA levels of IFN-γ, IFN-α, IFN-ß, interferon-stimulated gene 15 kDa (ISG-15), Mx2, Toll-like receptor 9 (TLR9), and interferon regulatory factor 7 (IRF7) were analyzed by real-time quantitative polymerase chain reaction. RESULTS: At 4 hours after PDT, CD4+ increased, accompanied by increased levels of mRNA expression of IFN-γ, but CD4+ and mRNA expression levels of IFN-γ were decreased at 24 hours after PDT. CD123+ pDCs showed an increasing trend. CD1a+ LCs in the epidermis gradually decreased, and DCs in the epidermis gradually increased. CD3+ infiltrated and migrated to the superficial dermis, but CD8+ did not change significantly after PDT. The mRNA expression levels of IFN-α, IFN-ß, ISG-15, Mx2, TLR9, and IRF7 showed an increasing trend after PDT. As compared with the patients without significantly increased IFN-α and IFN-ß after PDT sessions, patients with significant increases needed fewer sessions of PDT for remission. CONCLUSIONS: PDT for genital warts can activate T lymphocyte-mediated, DC-related, and pDC-related immunity. The clinical efficacy of PDT for genital warts may be related to the increased levels of IFN-α and IFN-ß after treatment.


Assuntos
Ácido Aminolevulínico/farmacologia , Condiloma Acuminado/tratamento farmacológico , Epiderme/imunologia , Células de Langerhans/imunologia , Fotoquimioterapia , Fármacos Fotossensibilizantes/farmacologia , Adulto , Ácido Aminolevulínico/uso terapêutico , Antígenos CD1/metabolismo , Complexo CD3/metabolismo , Contagem de Linfócito CD4 , Linfócitos T CD8-Positivos/imunologia , Citocinas/genética , Epiderme/metabolismo , Feminino , Expressão Gênica/efeitos dos fármacos , Humanos , Fator Regulador 7 de Interferon/genética , Interferon-alfa/genética , Interferon beta/genética , Interferon gama/genética , Subunidade alfa de Receptor de Interleucina-3/metabolismo , Células de Langerhans/efeitos dos fármacos , Células de Langerhans/metabolismo , Masculino , Pessoa de Meia-Idade , Proteínas de Resistência a Myxovirus/genética , Fármacos Fotossensibilizantes/uso terapêutico , RNA Mensageiro/metabolismo , Receptor Toll-Like 9/genética , Ubiquitinas/genética , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...